Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
315 E Broadway
Fl 4
Louisville, KY 40202Phone+1 502-629-2500Fax+1 502-629-2055
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2000- Duke University HospitalResidency, Internal Medicine, 1995 - 1996
- Duke University HospitalResidency, Internal Medicine, 1992 - 1993
Nishtar Medical CollegeClass of 1984
Certifications & Licensure
IN State Medical License 2000 - 2025
KY State Medical License 2008 - 2025
AZ State Medical License 2011 - 2016
NC State Medical License 1999 - 2004- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 232 citationsA phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.Evan M. Hersh, Steven J. O'Day, John D. Powderly, K. Khan, Anna C. Pavlick
Investigational New Drugs. 2011-06-01 - 8 citationsPhase i study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemiaDavid A. Rizzieri, Samantha LoRusso, William Tse, Khuda Dad Khan, Anjali S. Advani
Clinical Lymphoma, Myeloma & Leukemia. 2010-06-01 - 186 citationsPhase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Lymphoma and Anaplastic Large-Cell LymphomaStephen M. Ansell, Steven M. Horwitz, Andreas Engert, K. Khan, Thomas Lin
Journal of Clinical Oncology. 2007-07-01
Press Mentions
ESPN's Bob Valvano, Jim Valvano's Brother, Announces He Has CancerApril 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
